Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies [Phase 4]

View source ↗

Summary

Phase 4 study evaluating pharmacokinetics, efficacy, and safety of Belumosudil in Chinese adolescents with chronic graft-versus-host disease unresponsive to glu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Sanofi | Conditions: Chronic Graft Versus Host Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING